The day reveals AI deployment splitting into two incompatible economies. On one track, Google is embedding purchasing directly into Gemini in India, Meta is shipping consumer AI devices with deliberately soft edges, and South Korea's government is doubling down on national AI ambition, all treating AI as infrastructure to be normalized and monetized at scale. On the other track, the actual costs of that normalization are surfacing: Blue Cross Blue Shield documented $942 million in additional healthcare spending tied to hospital AI adoption over two years, a figure that exposes the gap between vendor promises and market reality. Simultaneously, venture-backed AI companies are going public with revenues that barely register against their valuations, while European multinationals are using AI regulation as a negotiating lever for investment incentives, and attackers are industrializing account hijacking against AI infrastructure itself. The pattern is clear: capital is rushing to embed AI into consumer and enterprise workflows before the true operating costs, security liabilities, and regulatory friction become undeniable. The question is whether the cost curve inverts before the installed base locks in.
Sloane Duvall